1. Denmark Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
ExpreS2ion Biotech Holding AB (publ)

ExpreS2ion Biotech Holding AB (publ)

EXPRS2.ST
ExpreS2ion Biotech Holding AB (publ)SE flagStockholm Stock Exchange
1.46
SEK
-0.09
- -
3.72MMarket Cap

Total Valuation

ExpreS2ion Biotech Holding AB (publ) carries a market capitalization of 3.72M, placing it among publicly traded companies globally. Its enterprise value stands at 38.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.72M
Enterprise Value38.58M

Share Statistics

ExpreS2ion Biotech Holding AB (publ) currently has 9.88M shares outstanding.

Shares Outstanding9.88M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 17.81, and the price-to-book ratio stands at 3.82.

PE RatioN/A
PS Ratio17.81
PB Ratio3.82
P/TBV Ratio2.40
P/FCF Ratio-5.78
P/OCF Ratio-1.30

Enterprise Valuation

EV / Sales11.47
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

ExpreS2ion Biotech Holding AB (publ) maintains a current ratio of 1.87, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.96, indicating elevated leverage, while an interest coverage ratio of -186.10 demonstrates limited ability to service its debt obligations.

Current Ratio1.87
Quick Ratio0.95
Debt / Equity1.96
Debt / EBITDA-0.01
Interest Coverage-186.10

Financial Efficiency

Return on Equity (ROE)-263.48
Return on Assets (ROA)-55.32
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory TurnoverN/A

Taxes

Income Tax-7.03M
Effective Tax RateN/A

Stock Price Statistics

ExpreS2ion Biotech Holding AB (publ)'s stock has declined approximately -94.59259% over the past 52 weeks. The 50-day moving average sits at 1.79, while the 200-day moving average is 10.70.

Beta (5Y)N/A
52-Week Price Change-94.59259%
50-Day Moving Average1.79
200-Day Moving Average10.70
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, ExpreS2ion Biotech Holding AB (publ) generated 3.36M in revenue and converted that into -36.23M in net income, yielding earnings per share of -0.95. EBITDA reached -43.55M, while operating income came in at -43.55M.

Revenue3.36M
Gross Profit-644,000.00
Operating Income-43.55M
Pretax Income-43.27M
Net Income-36.23M
EBITDA-43.55M
EBIT-43.55M
Earnings Per Share (EPS)-0.95

Balance Sheet

ExpreS2ion Biotech Holding AB (publ) holds 21.84M in cash and equivalents against 517,000.00 in total debt, resulting in a net debt position of -21.33M. Total book value stands at 15.69M, with working capital of 20.05M providing operational flexibility.

Cash & Cash Equivalents21.84M
Total Debt517,000.00
Net Debt-21.33M
Equity (Book Value)15.69M
Book Value Per Share1.83
Working Capital20.05M

Cash Flow

ExpreS2ion Biotech Holding AB (publ) produced -46.05M in operating cash flow over the past twelve months.

Operating Cash Flow-46.05M
Capital ExpendituresN/A
Free Cash Flow-46.05M
FCF Per Share-5.37

Margins

ExpreS2ion Biotech Holding AB (publ) operates with a gross margin of -19.15, reflecting its pricing power and cost economics. The operating margin of -1,294.92 and net profit margin of -1,077.46 provide insight into operational efficiency.

Gross Margin-19.15
Operating Margin-1,294.92
Pretax Margin-1,286.56
Profit Margin-1,077.46
EBITDA Margin-1,294.92

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-17.75
FCF Yield-17.30

Stock Splits

ExpreS2ion Biotech Holding AB (publ)'s most recent stock split took place on October 30, 2024 with a 40:1 split ratio.

Last Split Date10/30/2024
Split Ratio40:1

Scores

ExpreS2ion Biotech Holding AB (publ) posts an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.87